Composition : \n \nGabapentin USP 300 mg. \n \n  \n \nIndications : \n \nEpilepsy : \n \n? Monotherapy and Adjunctive treatment of partial seizures with and without secondary generalization in patients > 12 years of age. \n \n? Adjunctive treatment of partial seizures with and without secondary generalization in patients 2 - 12 years of age. \n \nPeripheral neuropathic pain : painful diabetic neuropathy and post-herpetic neuralgia. \n \nMigraine prophylaxis (unlicensed) \n \n  \n \nDosage & Administration :?Epilepsy \n \nMonotherapy and Adjunctive treatment in adults : Initially 300 mg 3 times daily and dose can be increased up to 3600 mg in 3 divided doses. \n \nChildren (adjunctive therapy only) : 2 - 6 years : 30 ? 70 mg / kg daily in 3 divided doses. \n \n6 ? 12 years : 25 ? 35 mg / kg daily in 3 divided doses. 12 - 18 years: Initially 300 mg 3 times daily and dose can be increased up to 900 - 3600 mg in 3 divided doses. \n \nPeripheral neuropathic pain \n \nAdults over 18 years : Initially 300 mg 3 times daily and dose can be increased up to 3600 mg in 3 divided doses. \n \nMigraine prophylaxis (unlicensed) \n \nInitially 300 mg daily, increased according to response up to 2400 mg daily in 3 divided doses.